GELESIS HOLDINGS, INC.: Nasdaq/NYSE listing notice — Gelesis receives NYSE delisting notice for market cap and equity below $50M thresholds

GELESIS HOLDINGS, INC.

Received NYSE notice on Nov 16, 2022 for non-compliance with Section 802.01B: market cap <$50M and equity <$50M over 30-day periods.
Has 45 days to submit a plan to cure; cure period up to 18 months if plan accepted by NYSE.
Common stock will continue trading under GLS with .BC designation during cure period.
Company intends to contact NYSE within 10 days and develop a compliance plan.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

GELESIS HOLDINGS, INC. received a nyse deficiency notice notice regarding market value (rules 802.01B).

Exchange: nyse
Notice: deficiency notice
Deficiency: market value
Rules: 802.01B

Exact text from the filing

November 16, 2022, Gelesis Holdings, Inc. (the “Company”) received a notification letter (the “Notice”) from the New York Stock Exchange (the “NYSE”) advising that it was not in compliance with the continued listing standard set forth in Section 802.01B of the NYSE Listed Company Manual because its total market capitalization was less than $50 million over a 30 trading-day period and its stockholders’ equity was less than $50 million over a separate 30 trading-day period. The Company’s common stock will continue to be listed and traded on the NYSE during the Cure Period referred to below, subj

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0000950170-22-025462

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.